Article Sidebar

pdf
Date Published: 30/08/2023
Abstract Views: 133
Views pdf: 93
DOI: https://doi.org/10.51298/vmj.v529i1B.6345
Issue
Vol. 529 No. 1B (2023)
Section
Các bài báo
How to Cite
Đồng, P. K., Vũ, Đình P., Trịnh, T. N., Nguyễn, V. P., & Đỗ, Q. P. (2023). RESULTS OF ECMO INTERVENTION IN THE MANAGEMENT OF COVID-19 PATIENTS AT THE NATIONAL HOSPITAL OF TROPICAL DISEASES. Vietnam Medical Journal, 529(1B). https://doi.org/10.51298/vmj.v529i1B.6345

RESULTS OF ECMO INTERVENTION IN THE MANAGEMENT OF COVID-19 PATIENTS AT THE NATIONAL HOSPITAL OF TROPICAL DISEASES

Phú Khiêm Đồng1,, Đình Phú Vũ1, Thị Nhung Trịnh1, Văn Phương Nguyễn1, Quốc Phong Đỗ2
1 Central Hospital for Tropical Diseases
2 E hospital

Main Article Content

Abstract

Objective: To evaluate the outcomes of ECMO application in the treatment of COVID-19 patients at the National Hospital of Tropical Diseases. Methods: Descriptive observational study of COVID-19 patients receiving ECMO intervention, conducted from March 2020 to March 2022. Results: A total of 58 eligible patients were included, with males accounting for 50% and a mean age of 48±16 years. Among them, 49 patients (72.4%) had underlying comorbidities, with cardiovascular disease, pregnancy, and diabetes being the most common, accounting for 34.5%, 27.6%, and 19%, respectively. Prior to ECMO initiation, the mean Murray score and SOFA score were 3.5 and 6, respectively, and the average duration of mechanical ventilation was 6.3 days. All patients received VV-ECMO, and the average ECMO run time, ICU length of stay, and hospital length of stay were 27.4, 44.2, and 47.7 days, respectively. Thrombocytopenia and severe bleeding were the most common complications, with rates of 58.6% and 34.5%, respectively. Treatment outcomes showed that 28 patients (48.3%) were discharged in stable condition. Conclusion: This is the first report in Vietnam to date on the outcomes of ECMO treatment in COVID-19 patients. The discharge rate of 48.3% is higher than some reports from Asian countries and similar to the results reported by ELSO

Article Details

Keywords

COVID-19; Extracorporeal membrane oxygenation (ECMO); Severe respiratory failure

References

1. Badulak J et al. (2021). Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J, 67(5):485-495.
2. Ling RR, et al. (2022). Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis. Crit Care, 26 (1):147.
3. Bộ Y tế. (2020). Hướng dẫn chẩn đoán và điều trị COVID19 do chủng vi rút Corona mới (SARS-COV-2). Quyết định số 1344-QĐ-BYT Ngày 25 tháng 3 năm 2020 của Bộ Trưởng Bộ Y Tế
4. Barbaro et al. (2021): Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet, 398(10307):1230-1238.
5. Indrambarya T et al. (2023). Mortality rate in patients with SAR-COV-2 infection treated with extracorporeal membrane oxygenator: A systematic review and meta-analysis. Heart Lung, 58:204-209.
6. Vũ Đình Phú; Đồng Phú Khiêm; Phạm Ngọc Thạch. (2020). Kết quả bước đầu áp dụng ECMO_VV điều trị bệnh nhân suy hô hấp cấp nặng tại khoa Hồi sức tích cực Bệnh viện Bệnh Nhiệt đới Trung Ương.Truyennhiemvietnam, 2(30).
7. Tran A, et al. (2023). Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Lancet Respir Med, 11(3):235-244.
8. Jin Y, Zhang Y, Liu J. (2022). Ischemic stroke and intracranial hemorrhage in extracorporeal membrane oxygenation for COVID-19: A systematic review and meta-analysis. Perfusion: 2676591221130886.